欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号AT/H/1022/001
药品名称Risperidone Pharmathen 25 mg
活性成分
    • risperidone 25.0 mg
剂型Powder and solvent for prolonged-release suspension for injection
上市许可持有人Pharmathen S.A. Dervenakion 6 Pallini 153 51 Greece
参考成员国 - 产品名称Austria (AT)
Risperidon Pharmathen 25 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension
互认成员国 - 产品名称
    • Ireland (IE)
许可日期2020/10/12
最近更新日期2024/07/02
药物ATC编码
    • N05AX08 risperidone
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Multiple (Copy) Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase